Table 1.
Duration of anti-C. difficile drug therapy.
| Anti-C. difficile Treatment | Patients | Duration of Treatment | Follow-up after the End of Anti-C. difficile Treatment | Bezlotoxumab Infusion Time from the Start of Treatment |
|---|---|---|---|---|
| Vancomycin + metronidazole | 5 | 10 (10–10) | 76 (75–79) | 2 (1–5) |
| Vancomycin | 40 | 11 (10–14) | 82 (77.5–86) | 6.5 (3–10) |
| Vancomycin (tapered) | 32 | 42 (35.5–55.5) | 62 (45–73) | 14 (3.5–29.5) |
| Fidaxomicin | 9 | 11 (10–13) | 79 (70.5–82) | 5 (2–8) |
| Fidaxomicin (extend regimen) | 4 | 24.5 (23–26.2) | 79 (71–88) | 12.5 (1.5–22) |
| FMT (after vancomycin) | 1 | 9 | 79 | 12 |
FMT: faecal microbiota transplant. Time is indicated in days; median (Q1–Q3).